JP2017537928A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537928A5
JP2017537928A5 JP2017529817A JP2017529817A JP2017537928A5 JP 2017537928 A5 JP2017537928 A5 JP 2017537928A5 JP 2017529817 A JP2017529817 A JP 2017529817A JP 2017529817 A JP2017529817 A JP 2017529817A JP 2017537928 A5 JP2017537928 A5 JP 2017537928A5
Authority
JP
Japan
Prior art keywords
syringe
nominal volume
range
nominal
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017529817A
Other languages
English (en)
Other versions
JP2017537928A (ja
JP6726666B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/078482 external-priority patent/WO2016087569A1/en
Publication of JP2017537928A publication Critical patent/JP2017537928A/ja
Publication of JP2017537928A5 publication Critical patent/JP2017537928A5/ja
Application granted granted Critical
Publication of JP6726666B2 publication Critical patent/JP6726666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

シリンジの公称容積は、１ｍｌから１５０ｍｌ、好ましくは２ｍｌから１２５ｍｌ、より好ましくは３ｍｌから１００ｍｌ、より好ましくは４ｍｌから７５ｍｌ、または５ｍｌから５０ｍｌの範囲の場合がある。好ましくは、シリンジの公称容積は、１ｍｌ、２ｍｌ、２．２５ｍｌ、２．５ｍｌ、３ｍｌ、４ｍｌ、５ｍｌ、１０ｍｌ、１５ｍｌ、２０ｍｌ、３０ｍｌ、４０ｍｌ、５０ｍｌ、７５ｍｌ、１００ｍｌ、１２５ｍｌ、または１５０ｍｌである。
JP2017529817A 2014-12-03 2015-12-03 免疫グロブリンを含む安定性が高められた医薬製品 Active JP6726666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14196069 2014-12-03
EP14196069.0 2014-12-03
PCT/EP2015/078482 WO2016087569A1 (en) 2014-12-03 2015-12-03 Pharmaceutical product with increased stability comprising immunoglobulins

Publications (3)

Publication Number Publication Date
JP2017537928A JP2017537928A (ja) 2017-12-21
JP2017537928A5 true JP2017537928A5 (ja) 2018-12-27
JP6726666B2 JP6726666B2 (ja) 2020-07-22

Family

ID=52002817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017529817A Active JP6726666B2 (ja) 2014-12-03 2015-12-03 免疫グロブリンを含む安定性が高められた医薬製品

Country Status (15)

Country Link
US (1) US20180264111A1 (ja)
EP (2) EP3226895B1 (ja)
JP (1) JP6726666B2 (ja)
KR (1) KR20170088995A (ja)
CN (1) CN106999588A (ja)
AU (1) AU2015357068B2 (ja)
BR (1) BR112017010442A2 (ja)
CA (1) CA2968915A1 (ja)
DK (1) DK3226895T3 (ja)
ES (1) ES2825704T3 (ja)
HU (1) HUE052280T2 (ja)
MX (1) MX2017007156A (ja)
PL (1) PL3226895T3 (ja)
RU (1) RU2748841C2 (ja)
WO (1) WO2016087569A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA038462B1 (ru) 2014-10-23 2021-08-31 Эмджен Инк. Снижение вязкости фармацевтических составов
JP7377596B2 (ja) * 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
TW202348250A (zh) * 2017-07-24 2023-12-16 美商再生元醫藥公司 穩定化之抗體組合物及其製法
US20220323670A1 (en) * 2021-04-08 2022-10-13 Genixus, Corp. Syringe prefilled with pharmaceutical fluid
WO2023102398A2 (en) * 2021-11-30 2023-06-08 Sab, Llc Ungulate-derived polyclonal immunoglobulin specific for influenza virus and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
KR20050042210A (ko) * 2001-11-02 2005-05-06 메리디안 메디칼 테크놀로지즈 인코포레이티드 약제 콘테이너, 약물 투여용 약제 분배 키트 및 그것을패키징하는 방법
EP1539212A4 (en) 2002-07-12 2007-05-02 Medarex Inc METHOD AND COMPOSITIONS FOR PREVENTING OXIDATIVE DEGRADATION OF PROTEINS
EP1767347A1 (de) * 2005-09-27 2007-03-28 Alcan Technology & Management Ltd. Deckfolie für Blisterverpackungen
US8852167B2 (en) 2005-12-01 2014-10-07 Bayer Medical Care Inc. Medical connector
GB0619060D0 (en) 2006-09-27 2006-11-08 Glaxosmithkline Biolog Sa Novel process
GB2471726B (en) * 2009-07-10 2013-09-11 Oval Medical Technologies Ltd A pre-filled syringe including an oxygen absorber
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
EA032625B1 (ru) * 2011-05-02 2019-06-28 Милленниум Фармасьютикалз, Инк. КОМПОЗИЦИЯ АНТИ-α4β7 АНТИТЕЛА
FR2995213A1 (fr) * 2012-09-12 2014-03-14 Lfb Biotechnologies Seringue contenant une composition, notamment pharmaceutique, comprenant des immunoglobulines, son procede de fabrication et son utilisation
BR112015021586B1 (pt) * 2013-03-14 2023-01-31 Fresenius Kabi Deutschland Gmbh Formulação de morfina farmacêutica injetável e kit
EP3424547A1 (en) * 2013-03-14 2019-01-09 Fresenius Kabi Austria GmbH Packaging system for oxygen-sensitive drugs
AU2015326037A1 (en) * 2014-10-02 2017-04-13 Terumo Kabushiki Kaisha Medical container for accommodating protein solution preparation therein

Similar Documents

Publication Publication Date Title
JP2016028092A5 (ja)
JP2018012698A5 (ja)
JP2016065085A5 (ja)
JP2015503422A5 (ja)
EA201790630A1 (ru) Способы получения рибозидов
WO2016011222A3 (en) Circular polynucleotides
JP2015053053A5 (ja)
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
EA201691991A1 (ru) Мультиспецифические антитела
JP2016502162A5 (ja)
JP2014237817A5 (ja)
JP2016027901A5 (ja)
TWD173737S (zh) 肌肉鍛鍊機器
JP2018533683A5 (ja)
JP2017537928A5 (ja)
JP2015505555A5 (ja)
JP2015186128A5 (ja)
JP2015173751A5 (ja)
WO2015138532A3 (en) Methods for the treatment of kidney fibrosis
JP2016540026A5 (ja)
JP2016540019A5 (ja)
JP2015016294A5 (ja)
JP2016053220A5 (ja)
JP2016038993A5 (ja)
JP2017516883A5 (ja)